Overview

A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies

Status:
Recruiting

Trial end date:
2025-12-31

Target enrollment:

Participant gender:

Summary

An open, multi-center, randomized trial comparing haploidentical HSCTs from young non-first-degree and older first-degree donors in hematological malignancies

Phase:

Phase 3

Details

Lead Sponsor:

First Affiliated Hospital of Zhejiang University

Treatments:

Antilymphocyte Serum
Busulfan
Cyclophosphamide
Cyclosporine
Cyclosporins
Cytarabine
Mycophenolic Acid
Thymoglobulin